Drug and Therapeutics Bulletin 1995;33:6-8; doi:10.1136/dtb.1995.3316
Copyright © 1995 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Management of patients with thrombophilia

In broad terms patients who have a propensity to thrombosis do so because they have a disorder of the blood (e.g. a coagulation defect or a cellular abnormality such as polycythaemia) or a defect of the vessel wall. Where enhanced coagulation is the primary cause the disorder is referred to as thrombophilia.1 In this article we review the causes, diagnosis and management of thrombophilia.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1995 BMJ Publishing Group Ltd.